Goyal R, Singhal M, Jialal I. Type 2 Diabetes. 2023 [cited 2024 Nov 4]; Available from: https://www.ncbi.nlm.nih.gov/books/NBK513253/

Majid H, Kohli S, Islam SU, Nidhi N. The role of branched chain aminotransferase in the interrelated pathways of type 2 diabetes mellitus and Alzheimer’s disease. J Diabetes Metab Disord. 2025;24:1–15. https://doi.org/10.1007/s40200-025-01597-6.

Article  CAS  Google Scholar 

Diabetes Facts and Figures|International Diabetes Federation. [cited 2024 Nov 10]. Available from: https://idf.org/about-diabetes/diabetes-facts-figures/

Rojas M, Chávez-Castillo M, Bautista J, Ortega Á, Nava M, Salazar J, et al. Alzheimer’s disease and type 2 diabetes mellitus: pathophysiologic and pharmacotherapeutics links. World J Diabetes. 2021;12:745.

Article  PubMed  PubMed Central  Google Scholar 

Chauhan A, Dubey S, Jain S. Association between type 2 diabetes mellitus and alzheimer’s disease: common molecular mechanism and therapeutic targets. Cell Biochem Funct. 2024;42:e4111. https://doi.org/10.1002/cbf.4111.

Article  CAS  PubMed  Google Scholar 

Diniz Pereira J, Gomes Fraga V, Morais Santos AL, Carvalho das MG, Caramelli P, Braga Gomes K. Alzheimer’s disease and type 2 diabetes mellitus: a systematic review of proteomic studies. J Neurochem. 2021;156:753–76. https://doi.org/10.1111/jnc.15166.

Article  CAS  PubMed  Google Scholar 

Nodirahon A, Majid H, Waghdhare S, Vohora D, Nidhi N. The effect of sodium glucose Co-transport 2 inhibitors on cognitive impairment and depression in type 2 diabetes mellitus patients. Clin Epidemiol Glob Health. 2024;26:101555.

Article  CAS  Google Scholar 

Cade WT. Diabetes-related microvascular and macrovascular diseases in the physical therapy setting. Phys Ther. 2008;88:1322–35.

Article  PubMed  PubMed Central  Google Scholar 

Lee J. Mild cognitive impairment in relation to Alzheimer’s disease: an investigation of principles, classifications, ethics, and problems. Neuroethics. 2023;16:16.

Article  Google Scholar 

Vanweert F, Schrauwen P, Phielix E. Role of branched-chain amino acid metabolism in the pathogenesis of obesity and type 2 diabetes-related metabolic disturbances BCAA metabolism in type 2 diabetes. Nutr Diabetes. 2022;12:35.

Article  CAS  PubMed  PubMed Central  Google Scholar 

What is Alzheimer’s Disease? Symptoms & Causes | alz.org. [cited 2024 Nov 4]. Available from: https://www.alz.org/alzheimers-dementia/what-is-alzheimers

What Happens to the Brain in Alzheimer’s Disease? | National Institute on Aging. [cited 2024 Nov 4]. Available from: https://www.nia.nih.gov/health/alzheimers-causes-and-risk-factors/what-happens-brain-alzheimers-disease

Crawford L, Loprinzi PD. Alzheimer’s Disease: Memory Interference and the Role of Exercise. Alzheimer’s Disease. 2019 [cited 2024 Nov 4];193–204. Available from: https://www.ncbi.nlm.nih.gov/books/NBK552139/

2023 Alzheimer’s disease facts and figures. Alzheimer’s & Dementia. 2023;19:1598–695. https://doi.org/10.1002/alz.13016

2020 Alzheimer’s disease facts and figures. Alzheimer’s & Dementia. 2020;16:391–460. https://doi.org/10.1002/alz.12068

Bondi MW, Edmonds EC, Salmon DP. Alzheimer’s disease: past, present, and future. J Int Neuropsychol Soc. 2017;23:818.

Article  PubMed  PubMed Central  Google Scholar 

Aramadaka S, Mannam R, Narayanan RS, Bansal A, Yanamaladoddi VR, Sarvepalli SS, et al. Neuroimaging in Alzheimer’s disease for early diagnosis: a comprehensive review. Cureus. 2023;15:38544.

Google Scholar 

Mirzaei N, Shi H, Oviatt M, Doustar J, Rentsendorj A, Fuchs DT, et al. Alzheimer’s retinopathy: seeing disease in the eyes. Front Neurosci. 2020;14: 566483.

Article  Google Scholar 

Kueper JK, Speechley M, Montero-Odasso M. The Alzheimer’s disease Assessment Scale-Cognitive Subscale (ADAS-Cog): modifications and responsiveness in pre-dementia populations. A narrative review. J Alzheimer’s Dis. 2018;63:423.

Article  Google Scholar 

Cognitive Assessment Tools | Alzheimer’s Association. [cited 2024 Nov 6]. Available from: https://www.alz.org/professionals/health-systems-medical-professionals/clinical-resources/cognitive-assessment-tools

Palsetia D, Rao G, Tiwari S, Lodha P, De Sousa A. The clock drawing test versus mini-mental status examination as a screening tool for dementia: a clinical comparison. Indian J Psychol Med. 2018;40:1.

Article  PubMed  PubMed Central  Google Scholar 

Rakusa M, Jensterle J, Mlakar J. Clock drawing test: a simple scoring system for the accurate screening of cognitive impairment in patients with mild cognitive impairment and dementia. Dement Geriatr Cogn Disord. 2018;45:326–34. https://doi.org/10.1159/000490381.

Article  PubMed  Google Scholar 

Seitz DP, Chan CCH, Newton HT, Gill SS, Herrmann N, Smailagic N, et al. Mini-Cog for the detection of dementia within a primary care setting. Cochrane Database Syst Rev. 2021;2021:CD011415.

PubMed Central  Google Scholar 

Hnilicova P, Kantorova E, Sutovsky S, Grofik M, Zelenak K, Kurca E, et al. Imaging methods applicable in the diagnostics of Alzheimer’s disease, considering the involvement of insulin resistance. Int J Mol Sci. 2023;24:3325.

Article  PubMed  PubMed Central  Google Scholar 

Wu T, Lin D, Cheng Y, Jiang S, Riaz MW, Fu N, et al. Amyloid cascade hypothesis for the treatment of alzheimer’s disease: progress and challenges. Aging Dis. 2022;13:1745.

Article  PubMed  PubMed Central  Google Scholar 

Langerscheidt F, Wied T, Al Kabbani MA, van Eimeren T, Wunderlich G, Zempel H. Genetic forms of tauopathies: inherited causes and implications of Alzheimer’s disease-like TAU pathology in primary and secondary tauopathies. J Neurol. 2024;271:2992–3018.

Article  PubMed  PubMed Central  Google Scholar 

Nadeem M, Majid H, Ansari MD, Ahmad FJ, Parvez S, Akhtar M, et al. Development and optimization of piracetam and shatavarin IV-loaded nanoemulsion for alzheimer’s disease therapy: in silico and experimental analysis. ACS Omega. 2025. https://doi.org/10.1021/acsomega.4c09072.

Article  PubMed  PubMed Central  Google Scholar 

Toral-Rios D, Pichardo-Rojas PS, Alonso-Vanegas M, Campos-Peña V. GSK3β and Tau protein in Alzheimer’s disease and epilepsy. Front Cell Neurosci. 2020;14:19.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou Q, Li S, Li M, Ke D, Wang Q, Yang Y, et al. Human tau accumulation promotes glycogen synthase kinase-3β acetylation and thus upregulates the kinase: a vicious cycle in Alzheimer neurodegeneration. EBioMedicine. 2022;78: 103970.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jewett BE, Thapa B. Physiology, NMDA Receptor. StatPearls. 2022 [cited 2024 Nov 10]; Available from: https://www.ncbi.nlm.nih.gov/books/NBK519495/

Glutamate: What It Is & Function. [cited 2024 Nov 10]. Available from: https://my.clevelandclinic.org/health/articles/22839-glutamate

Wang R, Reddy PH. Role of glutamate and NMDA receptors in Alzheimer’s disease. J Alzheimers Dis. 2017;57:1041.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xie J, Van Hoecke L, Vandenbroucke RE. The impact of systemic inflammation on Alzheimer’s disease pathology. Front Immunol. 2022;12:796867.

Article  PubMed  PubMed Central  Google Scholar 

Wu K-M, Zhang Y-R, Huang Y-Y, Dong Q, Tan L, Yu J-T. The role of the immune system in Alzheimer’s disease. Ageing Res Rev. 2021;70: 101409.

Article  CAS  PubMed  Google Scholar 

Yan X, Hu Y, Wang B, Wang S, Zhang X. Metabolic Dysregulation Contributes to the Progression of Alzheimer’s Disease. Front Neurosci. 2020;14.

Sędzikowska A, Szablewski L. Insulin and insulin resistance in Alzheimer’s disease. Int J Mol Sci. 2021;22:9987.

Article  PubMed  PubMed Central  Google Scholar 

Eisenmenger LB, Peret A, Famakin BM, Spahic A, Roberts GS, Bockholt JH, et al. Vascular contributions to Alzheimer’s disease. Transl Res. 2023;254:41–53.

Article  CAS  PubMed  Google Scholar 

Sehrawat A, Mishra J, Mastana SS, Navik U, Bhatti GK, Reddy PH, et al. Dysregulated autophagy: A key player in the pathophysiology of type 2 diabetes and its complications. Biochim Biophys Acta (BBA) Mol Basis Dis. 2023;186:166666.

Article  Google Scholar 

Zhao X, Bie LY, Pang DR, Li X, Yang LF, Chen DD, et al. The role of autophagy in the treatment of type II diabetes and its complications: a review. Front Endocrinol (Lausanne). 2023;14:1228045.

Article  PubMed  PubMed Central  Google Scholar 

Wang Y, Liu Z, Shu S, Cai J, Tang C, Dong Z. AMPK/mTOR signaling in autophagy regulation during cisplatin-induced acute kidney injury. Front Physiol. 2020;11: 619730.

Article  PubMed  PubMed Central